NØK BIOVARME AS

2500 TYNSET

Finances

Return on Equity

−4,59 %

Current Ratio

1,33

Debt-to-Equity Ratio

1,16

Key figures (NOK)	2022	2021	2020	2019
Revenue	13 672 000	14 335 000	11 891 000	13 407 000
Net Income	−786 000	608 000	−659 000	805 000
Total Assets	42 742 000	45 082 000	46 825 000	49 937 000
Total Equity	17 129 000	18 346 000	17 738 000	18 397 000

Income (NOK)	2022	2021	2020	2019
Revenue	13 672 000	14 335 000	11 891 000	13 407 000
Expenditure	14 323 000	13 106 000	11 947 000	11 905 000
Operating Profit	−652 000	1 229 000	−57 000	1 502 000
Financial Income	121 000	111 000	60 000	156 000
Financial Costs	482 000	586 000	852 000	640 000
Financial Balance	−361 000	−475 000	−792 000	−484 000
Earnings Before Tax	−1 012 000	753 000	−849 000	1 018 000
Tax	−227 000	145 000	−190 000	213 000
Net Income	−786 000	608 000	−659 000	805 000

Balance (NOK)	2022	2021	2020	2019
Total Fixed Assets	35 112 000	37 351 000	38 885 000	41 114 000
Total Current Assets	7 630 000	7 731 000	7 940 000	8 823 000
Total Assets	42 742 000	45 082 000	46 825 000	49 937 000
Total Retained Equity	4 129 000	5 346 000	4 738 000	5 397 000
Total Equity	17 129 000	18 346 000	17 738 000	18 397 000
Total Long-Term Debt	19 878 000	22 554 000	25 641 000	25 694 000
Total Current Debt	5 735 000	4 182 000	3 447 000	5 846 000
Total Equity and Debt	42 742 000	45 082 000	46 825 000	49 937 000

Cash flow (NOK)	2022	2021	2020	2019
Sales Income	13 612 000	14 275 000	11 831 000	13 347 000
Other Income	60 000	60 000	60 000	60 000
Revenue	13 672 000	14 335 000	11 891 000	13 407 000
Cost of Goods Sold	6 786 000	6 909 000	5 641 000	5 890 000
Salary Costs	2 093 000	1 886 000	1 816 000	1 834 000
Depreciation	2 977 000	2 829 000	2 838 000	2 485 000
Impairment	0	0	0	0
Expenditure	14 323 000	13 106 000	11 947 000	11 905 000
Operating Profit	−652 000	1 229 000	−57 000	1 502 000
Financial Income	121 000	111 000	60 000	156 000
Financial Costs	482 000	586 000	852 000	640 000
Financial Balance	−361 000	−475 000	−792 000	−484 000
Dividends	0	0	0	0
Net Income	−786 000	608 000	−659 000	805 000

Balance details (NOK)	2022	2021	2020	2019
Goodwill	0	0	0	0
Total Intangible Assets	179 000	24 000	24 000	0
Real Eastate	34 158 000	36 633 000	38 269 000	40 540 000
Machinery and Plant Facilities	0	0	0	0
Fixtures	55 000	0	0	4 000
Total Tangible Assets	34 214 000	36 633 000	38 269 000	40 543 000
Total Fiancial Fixed Assets	720 000	694 000	592 000	571 000
Total Fixed Assets	35 112 000	37 351 000	38 885 000	41 114 000
Stock	507 000	511 000	475 000	570 000
Total Investments	0	0	0	0
Cash, Bank	4 342 000	5 070 000	6 347 000	6 726 000
Total Current Assets	7 630 000	7 731 000	7 940 000	8 823 000
Total Assets	42 742 000	45 082 000	46 825 000	49 937 000
Total Equity	17 129 000	18 346 000	17 738 000	18 397 000
Short-Term Group Debt	513 000	141 000	625 000	24 000
Total Long-Term Debt	19 878 000	22 554 000	25 641 000	25 694 000
Creditors	1 787 000	1 786 000	1 325 000	5 294 000
Unpaid Taxes	1 271 000	889 000	850 000	93 000
Dividends	0	0	0	0
Other Current Debt	2 165 000	1 156 000	647 000	303 000
Total Current Debt	5 735 000	4 182 000	3 447 000	5 846 000
Total Equity and Debt	42 742 000	45 082 000	46 825 000	49 937 000

Financial indicators	2022	2021	2020	2019
Return on Equity	−4,59 %	3,31 %	−3,72 %	4,38 %
Debt-to-Equity Ratio	1,16	1,23	1,45	1,4
Operating Profit Margin	−4,77 %	8,57 %	−0,48 %	11,2 %
Current Ratio	1,33	1,85	2,3	1,51
Quick Ratio	1,46	2,11	2,67	1,67
Equity Ratio	0,4	0,41	0,38	0,37
Gross Profit Margin	50,37 %	51,8 %	52,56 %	56,07 %